Search

Author/Creator Pollock, Pamela M.

1. Bcl‐2 inhibitors enhance FGFR inhibitor‐induced mitochondrial‐dependent cell death in FGFR2‐mutant endometrial cancer. Issue 4 (18th January 2019)

Authors:
Packer, Leisl M.; Stehbens, Samantha J.; Bonazzi, Vanessa F.; Gunter, Jennifer H.; Ju, Robert J.; Ward, Micheal; Gartside, Michael G.; Byron, Sara A.; Pollock, Pamela M.
Journal:
Molecular oncology
Issue:
Volume 13:Issue 4(2019)
Page Start:
738
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition. (1st February 2017)

Authors:
Eggink, Florine A.; Van Gool, Inge C.; Leary, Alexandra; Pollock, Pamela M.; Crosbie, Emma J.; Mileshkin, Linda; Jordanova, Ekaterina S.; Adam, Julien; Freeman-Mills, Luke; Church, David N.; Creutzberg, Carien L.; De Bruyn, Marco; Nijman, Hans W.; Bosse, Tjalling
Journal:
Oncoimmunology
Issue:
Volume 6:Number 2(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts. (November 2019)

Authors:
Shokoohmand, Ali; Ren, Jiongyu; Baldwin, Jeremy; Atack, Anthony; Shafiee, Abbas; Theodoropoulos, Christina; Wille, Marie-Luise; Tran, Phong A.; Bray, Laura J.; Smith, Deborah; Chetty, Naven; Pollock, Pamela M.; Hutmacher, Dietmar W.; Clements, Judith A.; Williams, Elizabeth D.; Bock, Nathalie
Journal:
Biomaterials
Issue:
Volume 220(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗